PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Probing new mechanisms of depression and anxiety

Mouse study reveals a molecular mechanism that may underlie depressive- and anxiety-like symptoms.

2025-11-24
(Press-News.org) In a new JNeurosci paper, Tian-Ming Gao and colleagues, from Southern Medical University, explored how adenosine triphosphate (ATP) signaling relates to depression and anxiety using male mice. ATP is a molecule that not only provides energy but also supports communication between neurons. The researchers focused on ATP signaling in a brain region implicated in depression called the hippocampus. 

Male mice that were more likely to acquire depressive- and anxiety-like symptoms following long-term stress had less ATP levels and reduced expression of a protein involved in ATP release (connexin 43). When the research team genetically dampened or deleted connexin 43 in cells that release ATP in another group of mice, this alone led to depressive- and anxiety-like behaviors and lowered ATP levels. Bridging the findings together, in distressed mice, restoring connexin 43 in the hippocampus brought ATP levels up to normal and improved behavioral outcomes. 

Says Gao, “This is the first direct evidence that deficient ATP release in [a region of the] hippocampus drives both depressive- and anxiety-like behaviors, revealing a shared molecular pathway [for these conditions].” Gao also emphasizes that the findings linking connexin 43 to this mechanism point to a potential treatment target for treating depression and anxiety when they occur at the same time. Of note, the researchers plan to assess both sexes in future studies. 

### 

Please contact media@sfn.org for full-text PDF. 

About JNeurosci 

JNeurosci was launched in 1981 as a means to communicate the findings of the highest quality neuroscience research to the growing field. Today, the journal remains committed to publishing cutting-edge neuroscience that will have an immediate and lasting scientific impact, while responding to authors' changing publishing needs, representing breadth of the field and diversity in authorship. 

About The Society for Neuroscience 

The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 35,000 members in more than 95 countries. 

END



ELSE PRESS RELEASES FROM THIS DATE:

What can psychedelics teach us about the sense of self?

2025-11-24
When people use a psychedelic called dimethyltryptamine (DMT), they experience a temporary loss of their sense of self. DMT interacts with a frequency of brain activity associated with self-referential processes (alpha waves), but it’s unclear how this activity relates to self-awareness. Christopher Timmerman, at University College London, and Marco Aqil, currently at the University of Miami, are among researchers who used DMT as a tool to explore the relationship between alpha waves and self-awareness.   As reported in their JNeurosci paper, the researchers discovered ...

An integrated monolithic synaptic device for C-tactile afferent perception and robot emotional interaction

2025-11-24
Human emotional interaction relies heavily on CT afferents—unmyelinated nerves in hairy skin that convert gentle tactile stimuli into affective states. For robots to engage in similar empathetic communication, existing tactile sensing technologies fall short: most rely on segregated "sensation-transmission-processing" modules, which cause latency accumulation and high energy consumption due to repeated analog-to-digital conversion. "Current neuromorphic devices for touch either lack low-threshold sensitivity or separate ...

‘Zap-and-freeze’ technique successfully used to watch human brain cell communication

2025-11-24
**EMBARGOED FOR RELEASE UNTIL NOV. 24 AT 12 NOON** Researchers at Johns Hopkins Medicine say they have used a “zap-and-freeze” technology to watch hard-to-see brain cell communications in living brain tissue from mice and humans. Findings from the new experiments, supported by the National Institutes of Health and published Nov. 24 in Neuron, could potentially help scientists find the root causes of nonheritable forms of Parkinson’s disease, the researchers say. Sporadic cases of Parkinson’s disease account for most ...

Prebiotic in diet linked to less impulsivity in gambling rats with TBI

2025-11-24
COLUMBUS, Ohio – Using a prebiotic to influence bacterial activity in the gut after a traumatic brain injury may help reduce impulsive behavior, one of the common symptoms to follow a moderate blow to the head, a new study in rats suggests. Following up on previous work showing a connection between negative changes to gut bacteria after a traumatic brain injury (TBI) and poor decision making, researchers at The Ohio State University are now exploring whether the gut problems may actually cause some long-term symptoms. They found that adding the prebiotic galacto-oligosaccharide (GOS) to rat diets before and after ...

Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation

2025-11-24
About The Study: In a cohort composed primarily of women with obesity, glucagon-like peptide-1 receptor agonist (GLP-1RA) use with subsequent pre-pregnancy or early pregnancy discontinuation was associated with more gestational weight gain and a higher risk of preterm delivery, gestational diabetes, and hypertensive disorders of pregnancy. Corresponding Authors: To contact the corresponding authors, email Jacqueline Maya, MD, (jmaya@mgh.harvard.edu) and Camille E. Powe, MD, (camille.powe@mgh.harvard.edu). To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.20951) Editor’s Note: Please ...

Increasing postpartum use of GLP-1 receptor agonists

2025-11-24
About The Study: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly used for postpartum weight loss since the introduction of semaglutide for weight loss in late 2022. Most users were overweight prior to pregnancy and only 23% had a documented diabetes diagnosis, suggesting that the primary indication for use was weight reduction. Corresponding Author: To contact the corresponding author, Mette Bliddal, PhD, email mbliddal@health.sdu.dk. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.20947) Editor’s Note: Please see the article for additional information, including ...

Patients who discontinued GLP-1s had more weight gain, complications during pregnancy

2025-11-24
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs. The findings are published in JAMA. “The use of glucagon-like peptide-1 receptor agonists—or GLP-1RAs—has increased dramatically, but recommendations suggest their discontinuation before pregnancy ...

Untreated sleep apnea raises risk of Parkinson’s, study finds

2025-11-24
New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson’s disease. However, they can significantly reduce the risk by improving the quality of their sleep by using continuous positive airway pressure, or CPAP. The study, which published today in the journal JAMA Neurology, examined electronic health records covering more than 11 million U.S. military veterans who received care through the Department of Veterans Affairs between 1999 and 2022. The research was led by Oregon Health & Science University ...

Prevalence, characteristics, and genetic architecture of avoidant/restrictive food intake phenotypes

2025-11-24
About The Study: This cohort study found that the prevalence of avoidant/restrictive food intake in the general pediatric population was substantial, and affected children had an associated elevated risk of developmental difficulties across multiple domains. The findings suggest a need for broad support interventions and advance understanding of the genetic underpinnings of avoidant/restrictive food intake.  Corresponding Author: To contact the corresponding author, Ludvig Daae Bjorndal, PhD, email l.d.bjorndal@psykologi.uio.no. To ...

Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity

2025-11-24
About The Study: In this post hoc analysis of the SURMOUNT-4 trial, among participants with obesity who achieved weight reduction with 36-week tirzepatide (a glucagon-like peptide-1 receptor agonist) treatment, withdrawing tirzepatide led to 25% or greater weight regain in most participants within 1 year and was associated with a greater reversal of their initial cardiometabolic parameter improvements compared with those who maintained weight reduction. These findings underscore the importance of continued obesity treatment.  Corresponding Author: To contact the corresponding author, Clare J. Lee, MD, MHS, ...

LAST 30 PRESS RELEASES:

LSU LCMC Health Cancer Center researchers uncover key immune differences in triple-negative breast cancer

University of Cincinnati study advances understanding of pancreatic cancer treatment resistance

An integrated approach to cybersecurity is key to reducing critical infrastructure vulnerability

Probing new mechanisms of depression and anxiety

What can psychedelics teach us about the sense of self?

An integrated monolithic synaptic device for C-tactile afferent perception and robot emotional interaction

‘Zap-and-freeze’ technique successfully used to watch human brain cell communication

Prebiotic in diet linked to less impulsivity in gambling rats with TBI

Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation

Increasing postpartum use of GLP-1 receptor agonists

Patients who discontinued GLP-1s had more weight gain, complications during pregnancy

Untreated sleep apnea raises risk of Parkinson’s, study finds

Prevalence, characteristics, and genetic architecture of avoidant/restrictive food intake phenotypes

Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity

US burden of disorders affecting the nervous system

Social media detox and youth mental health

One in two people in the US is affected by a neurological disease or disorder

Colliding ribosomes signal cellular stress

New doctoral network aims to establish optical vortex beams as key technology for advanced light-matter interaction

Vegan diet—even with ‘unhealthy’ plant-based foods—is better for weight loss than Mediterranean diet, finds new study

JMIR Publications joins STM and integrates STM’s Integrity Hub

NCSA receives honors in 2025 HPCwire Readers’ and Editors’ Choice Awards

New study reveals that differences between parent and child views best assess quality of life after pediatric liver transplant

Shapeshifting cancers’ masters, unmasked

Pusan National University researchers develop model to accurately predict vessel turnaround time

Nanowire breakthrough reveals elusive astrocytes

Novel liver cancer vaccine achieves responses in rare disease affecting children and young adults

International study finds gene linked with risk of delirium

Evidence suggests early developing human brains are preconfigured with instructions for understanding the world

Absolutely metal: scientists capture footage of crystals growing in liquid metal

[Press-News.org] Probing new mechanisms of depression and anxiety
Mouse study reveals a molecular mechanism that may underlie depressive- and anxiety-like symptoms.